This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe

Savings Deadline Expires In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
2-4 December 2024
Convention Centre DublinDublin, Ireland

Jason Dowd
Global Lead Cell Therapy Platform Process at Bayer
Speaker

Profile

Jason Dowd received his PhD from the University of British Columbia from the Michael Smith Biotech Lab and an MBA in Technology Management from the Open University in the UK. He has led the development of several biological products to marketing authorizations in major regulatory jurisdictions through pre-clinical, clinical and commercial stages. Recently at CCRM in Toronto as the Vice-President of Science and Technology, he led several research, development and GMP initiatives. Jason has returned to therapeutic product development with Bayer with a global role in allogeneic cell therapy platform development. Jason also has an adjunct professor role in the School of Engineering at McMaster University.

Agenda Sessions

  • Streamlining Allogeneic Product Development with Platform Automation in 2D and 3D Systems

    14:30